Maxcyte inc ipo
Web29 jul. 2024 · GAITHERSBURG, MD, July 29, 2024 - MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the pricing … Web14 apr. 2024 · MaxCyte, Inc. (NASDAQ:MXCT – Get Rating)’s share price traded up 3.4% on Wednesday . The stock traded as high as $5.22 and last traded at $5.12. 196,300 shares were traded during mid-day trading, a decline of 65% from the average session volume of 564,960 shares. The stock had previously closed at $4.95. Wall Street Analysts […]
Maxcyte inc ipo
Did you know?
Web12 jul. 2024 · MaxCyte, Inc (NASDAQ: MXCT) has files an up to $100,000,000 IPO. The company describes itself as: "We are a leading commercial cell engineering company … Web9 jul. 2024 · MaxCyte, which provides cell engineering devices and services, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company is …
WebUK establishments for MAXCYTE, INC. (FC033088) More for MAXCYTE, INC. (FC033088) Overseas company address 22 Firstfield Road, Suite 110, Gaithersburg, Md, United … WebMAXCYTE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) GlobeNewswire 1 week ago MaxCyte …
Web12 okt. 2024 · ROCKVILLE, Md., Oct. 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today … WebGaithersburg, Maryland-based MaxCyte, Inc. raised $14.4 million in its recent IPO on the London Stock Exchange’s AIM and commanded an opening market capitalization of …
Web30 jul. 2024 · MaxCyte, Inc. ( NASDAQ: MXCT) is a Gaithersburg, MD-based leading commercial cell engineering company that provides platform technologies to …
Web24 jan. 2024 · MaxCyte ended the year with 15 SPLs, including 4 SPLs added during 2024: Nkarta, Inc., Myeloid Therapeutics, Celularity, Inc. and Sana Biotechnology, Inc. Doug … how many super bowls did dan marino play inWeb30 jul. 2024 · MaxCyte, Inc., (NASDAQ: MXCT ), a leading provider of cell-engineering platform technologies, today announced the pricing of its upsized offering of 13,500,000 … how many super bowls did dan marino go toWeb30 jul. 2024 · GAITHERSBURG, Md., July 29, 2024 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today … how many super bowls did drew brees winWebCompany profile for MaxCyte, Inc. (MXCT) with a description, list of executives, contact details and other key facts. how did toby keith and wayman tisdale meetWeb1 dag geleden · ROCKVILLE, Md., April 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing … how did todd chrisley get custody of chloeWebMaxCyte Inc (MXCT) stock price, GURU trades, ... IPO Date. 2024-12-05. Description. MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. how did toby fox make his musicWebMaxcyte Inc. London AIM (United Kingdom) Maxcyte provides patented, high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and … how did tobacco affect jamestown